Picton Mahoney Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-188,640
Closed -$10.6M 218
2016
Q4
$10.6M Buy
+188,640
New +$11M 0.87% 45

Other funds holding MRK

Picton Mahoney Asset Management's MRK Position: Q2 2026 in Review

Picton Mahoney Asset Management increased its Merck (MRK) stake by 31% in Q2 2026, buying an estimated $4.87M and bringing the position to 176,844 shares worth $22.7M. The position accounts for 0.17% of the portfolio, ranked #114.

Picton Mahoney Asset Management first reported a position in MRK in Q2 2014 and has held it in 22 quarters since. The position peaked at $29.1M in Q2 2017. 3,298 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Picton Mahoney Asset Management held 176,844 shares of Merck worth $22.7M as of Q2 2026.
  • Picton Mahoney Asset Management bought 41,641 Merck shares in Q2 2026, an estimated $4.87M.
  • Merck made up 0.17% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #114 holding.
  • Picton Mahoney Asset Management first reported a position in Merck in Q2 2014 and has held it in 22 quarters since.
  • Picton Mahoney Asset Management's Merck position peaked at $29.1M in Q2 2017.
  • 3,298 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.